Copyright Reports & Markets. All rights reserved.

Global Herpes Simplex Virus Infections Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Herpes Simplex Virus Infections Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Herpes Simplex Virus Infections Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 General Treatment
    • 1.4.3 Antiviral Therapy
  • 1.5 Market by Application
    • 1.5.1 Global Herpes Simplex Virus Infections Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital
    • 1.5.3 Clinic
    • 1.5.4 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Herpes Simplex Virus Infections Market Perspective (2015-2026)
  • 2.2 Herpes Simplex Virus Infections Growth Trends by Regions
    • 2.2.1 Herpes Simplex Virus Infections Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Herpes Simplex Virus Infections Historic Market Share by Regions (2015-2020)
    • 2.2.3 Herpes Simplex Virus Infections Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Herpes Simplex Virus Infections Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Herpes Simplex Virus Infections Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Herpes Simplex Virus Infections Players by Market Size
    • 3.1.1 Global Top Herpes Simplex Virus Infections Players by Revenue (2015-2020)
    • 3.1.2 Global Herpes Simplex Virus Infections Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Herpes Simplex Virus Infections Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Herpes Simplex Virus Infections Market Concentration Ratio
    • 3.2.1 Global Herpes Simplex Virus Infections Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Herpes Simplex Virus Infections Revenue in 2019
  • 3.3 Herpes Simplex Virus Infections Key Players Head office and Area Served
  • 3.4 Key Players Herpes Simplex Virus Infections Product Solution and Service
  • 3.5 Date of Enter into Herpes Simplex Virus Infections Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Herpes Simplex Virus Infections Historic Market Size by Type (2015-2020)
  • 4.2 Global Herpes Simplex Virus Infections Forecasted Market Size by Type (2021-2026)

5 Herpes Simplex Virus Infections Breakdown Data by Application (2015-2026)

  • 5.1 Global Herpes Simplex Virus Infections Market Size by Application (2015-2020)
  • 5.2 Global Herpes Simplex Virus Infections Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Herpes Simplex Virus Infections Market Size (2015-2020)
  • 6.2 Herpes Simplex Virus Infections Key Players in North America (2019-2020)
  • 6.3 North America Herpes Simplex Virus Infections Market Size by Type (2015-2020)
  • 6.4 North America Herpes Simplex Virus Infections Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Herpes Simplex Virus Infections Market Size (2015-2020)
  • 7.2 Herpes Simplex Virus Infections Key Players in Europe (2019-2020)
  • 7.3 Europe Herpes Simplex Virus Infections Market Size by Type (2015-2020)
  • 7.4 Europe Herpes Simplex Virus Infections Market Size by Application (2015-2020)

8 China

  • 8.1 China Herpes Simplex Virus Infections Market Size (2015-2020)
  • 8.2 Herpes Simplex Virus Infections Key Players in China (2019-2020)
  • 8.3 China Herpes Simplex Virus Infections Market Size by Type (2015-2020)
  • 8.4 China Herpes Simplex Virus Infections Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Herpes Simplex Virus Infections Market Size (2015-2020)
  • 9.2 Herpes Simplex Virus Infections Key Players in Japan (2019-2020)
  • 9.3 Japan Herpes Simplex Virus Infections Market Size by Type (2015-2020)
  • 9.4 Japan Herpes Simplex Virus Infections Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Herpes Simplex Virus Infections Market Size (2015-2020)
  • 10.2 Herpes Simplex Virus Infections Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Herpes Simplex Virus Infections Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Herpes Simplex Virus Infections Market Size by Application (2015-2020)

11 India

  • 11.1 India Herpes Simplex Virus Infections Market Size (2015-2020)
  • 11.2 Herpes Simplex Virus Infections Key Players in India (2019-2020)
  • 11.3 India Herpes Simplex Virus Infections Market Size by Type (2015-2020)
  • 11.4 India Herpes Simplex Virus Infections Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Herpes Simplex Virus Infections Market Size (2015-2020)
  • 12.2 Herpes Simplex Virus Infections Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Herpes Simplex Virus Infections Market Size by Type (2015-2020)
  • 12.4 Central & South America Herpes Simplex Virus Infections Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Admedus Limited
    • 13.1.1 Admedus Limited Company Details
    • 13.1.2 Admedus Limited Business Overview and Its Total Revenue
    • 13.1.3 Admedus Limited Herpes Simplex Virus Infections Introduction
    • 13.1.4 Admedus Limited Revenue in Herpes Simplex Virus Infections Business (2015-2020))
    • 13.1.5 Admedus Limited Recent Development
  • 13.2 Agenus Inc.
    • 13.2.1 Agenus Inc. Company Details
    • 13.2.2 Agenus Inc. Business Overview and Its Total Revenue
    • 13.2.3 Agenus Inc. Herpes Simplex Virus Infections Introduction
    • 13.2.4 Agenus Inc. Revenue in Herpes Simplex Virus Infections Business (2015-2020)
    • 13.2.5 Agenus Inc. Recent Development
  • 13.3 Aicuris Anti-infective Cures Gmbh
    • 13.3.1 Aicuris Anti-infective Cures Gmbh Company Details
    • 13.3.2 Aicuris Anti-infective Cures Gmbh Business Overview and Its Total Revenue
    • 13.3.3 Aicuris Anti-infective Cures Gmbh Herpes Simplex Virus Infections Introduction
    • 13.3.4 Aicuris Anti-infective Cures Gmbh Revenue in Herpes Simplex Virus Infections Business (2015-2020)
    • 13.3.5 Aicuris Anti-infective Cures Gmbh Recent Development
  • 13.4 Asahi Kasei Corporation
    • 13.4.1 Asahi Kasei Corporation Company Details
    • 13.4.2 Asahi Kasei Corporation Business Overview and Its Total Revenue
    • 13.4.3 Asahi Kasei Corporation Herpes Simplex Virus Infections Introduction
    • 13.4.4 Asahi Kasei Corporation Revenue in Herpes Simplex Virus Infections Business (2015-2020)
    • 13.4.5 Asahi Kasei Corporation Recent Development
  • 13.5 Chimerix Inc.
    • 13.5.1 Chimerix Inc. Company Details
    • 13.5.2 Chimerix Inc. Business Overview and Its Total Revenue
    • 13.5.3 Chimerix Inc. Herpes Simplex Virus Infections Introduction
    • 13.5.4 Chimerix Inc. Revenue in Herpes Simplex Virus Infections Business (2015-2020)
    • 13.5.5 Chimerix Inc. Recent Development
  • 13.6 Clinigen Group Plc
    • 13.6.1 Clinigen Group Plc Company Details
    • 13.6.2 Clinigen Group Plc Business Overview and Its Total Revenue
    • 13.6.3 Clinigen Group Plc Herpes Simplex Virus Infections Introduction
    • 13.6.4 Clinigen Group Plc Revenue in Herpes Simplex Virus Infections Business (2015-2020)
    • 13.6.5 Clinigen Group Plc Recent Development
  • 13.7 Daewoong Pharmaceutical Co., Ltd.
    • 13.7.1 Daewoong Pharmaceutical Co., Ltd. Company Details
    • 13.7.2 Daewoong Pharmaceutical Co., Ltd. Business Overview and Its Total Revenue
    • 13.7.3 Daewoong Pharmaceutical Co., Ltd. Herpes Simplex Virus Infections Introduction
    • 13.7.4 Daewoong Pharmaceutical Co., Ltd. Revenue in Herpes Simplex Virus Infections Business (2015-2020)
    • 13.7.5 Daewoong Pharmaceutical Co., Ltd. Recent Development
  • 13.8 F. Hoffmann-la Roche Ltd.
    • 13.8.1 F. Hoffmann-la Roche Ltd. Company Details
    • 13.8.2 F. Hoffmann-la Roche Ltd. Business Overview and Its Total Revenue
    • 13.8.3 F. Hoffmann-la Roche Ltd. Herpes Simplex Virus Infections Introduction
    • 13.8.4 F. Hoffmann-la Roche Ltd. Revenue in Herpes Simplex Virus Infections Business (2015-2020)
    • 13.8.5 F. Hoffmann-la Roche Ltd. Recent Development
  • 13.9 Glaxosmithkline Plc
    • 13.9.1 Glaxosmithkline Plc Company Details
    • 13.9.2 Glaxosmithkline Plc Business Overview and Its Total Revenue
    • 13.9.3 Glaxosmithkline Plc Herpes Simplex Virus Infections Introduction
    • 13.9.4 Glaxosmithkline Plc Revenue in Herpes Simplex Virus Infections Business (2015-2020)
    • 13.9.5 Glaxosmithkline Plc Recent Development
  • 13.10 Maruho Co. Ltd.
    • 13.10.1 Maruho Co. Ltd. Company Details
    • 13.10.2 Maruho Co. Ltd. Business Overview and Its Total Revenue
    • 13.10.3 Maruho Co. Ltd. Herpes Simplex Virus Infections Introduction
    • 13.10.4 Maruho Co. Ltd. Revenue in Herpes Simplex Virus Infections Business (2015-2020)
    • 13.10.5 Maruho Co. Ltd. Recent Development
  • 13.11 Merck
    • 10.11.1 Merck Company Details
    • 10.11.2 Merck Business Overview and Its Total Revenue
    • 10.11.3 Merck Herpes Simplex Virus Infections Introduction
    • 10.11.4 Merck Revenue in Herpes Simplex Virus Infections Business (2015-2020)
    • 10.11.5 Merck Recent Development
  • 13.12 Mylan
    • 10.12.1 Mylan Company Details
    • 10.12.2 Mylan Business Overview and Its Total Revenue
    • 10.12.3 Mylan Herpes Simplex Virus Infections Introduction
    • 10.12.4 Mylan Revenue in Herpes Simplex Virus Infections Business (2015-2020)
    • 10.12.5 Mylan Recent Development
  • 13.13 Novartis
    • 10.13.1 Novartis Company Details
    • 10.13.2 Novartis Business Overview and Its Total Revenue
    • 10.13.3 Novartis Herpes Simplex Virus Infections Introduction
    • 10.13.4 Novartis Revenue in Herpes Simplex Virus Infections Business (2015-2020)
    • 10.13.5 Novartis Recent Development
  • 13.14 Sanofi Pasteur
    • 10.14.1 Sanofi Pasteur Company Details
    • 10.14.2 Sanofi Pasteur Business Overview and Its Total Revenue
    • 10.14.3 Sanofi Pasteur Herpes Simplex Virus Infections Introduction
    • 10.14.4 Sanofi Pasteur Revenue in Herpes Simplex Virus Infections Business (2015-2020)
    • 10.14.5 Sanofi Pasteur Recent Development
  • 13.15 Teva Pharmaceutical Industries Ltd.
    • 10.15.1 Teva Pharmaceutical Industries Ltd. Company Details
    • 10.15.2 Teva Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue
    • 10.15.3 Teva Pharmaceutical Industries Ltd. Herpes Simplex Virus Infections Introduction
    • 10.15.4 Teva Pharmaceutical Industries Ltd. Revenue in Herpes Simplex Virus Infections Business (2015-2020)
    • 10.15.5 Teva Pharmaceutical Industries Ltd. Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Herpes Simplex Virus Infections status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Herpes Simplex Virus Infections development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Admedus Limited
    Agenus Inc.
    Aicuris Anti-infective Cures Gmbh
    Asahi Kasei Corporation
    Chimerix Inc.
    Clinigen Group Plc
    Daewoong Pharmaceutical Co., Ltd.
    F. Hoffmann-la Roche Ltd.
    Glaxosmithkline Plc
    Maruho Co. Ltd.
    Merck
    Mylan
    Novartis
    Sanofi Pasteur
    Teva Pharmaceutical Industries Ltd.

    Market segment by Type, the product can be split into
    General Treatment
    Antiviral Therapy
    Market segment by Application, split into
    Hospital
    Clinic
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Herpes Simplex Virus Infections status, future forecast, growth opportunity, key market and key players.
    To present the Herpes Simplex Virus Infections development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Herpes Simplex Virus Infections are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now